bluebird bio
Jim DeTore, CFO (NASDAQ: BLUE) Headquarters: Cambridge, MA With its lentiviral-based gene therapy and gene editing capabilities, bluebird bio has built an integrated product platform with...
By: Alliance for Regenerative Medicine
Follow this link: